Morphological and biochemical features of obesity are associated with mineralization genes polymorphisms

International Journal of Obesity

Volumn 34, Issue 8, 2010, Pages 1308-1318

  Korostishevsky, M ^a   Cohen, Z ^a   Malkin, I ^a   Ermakov, S ^a   Yarenchuk, O ^a   Livshits, G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

gene interaction; genetic association study; mineralization genes and obesity; SNPs and haplotypes; variance component models

Indexed keywords

ALKALINE PHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR; LEPTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 GENE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERALIZATION; MORPHOLOGY; OBESITY; PEDIGREE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BODY MASS INDEX; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEPTIN; MALE; MIDDLE AGED; MODELS, GENETIC; OBESITY; PHENOTYPE; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYROPHOSPHATASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; WAIST-HIP RATIO; YOUNG ADULT;

EID: 77955469510     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.53     Document Type: Article

References (60)

1. Lee YS. The role of genes in the current obesity epidemic. Ann Acad Med Singapore 2009; 38: 45-47.
2. Pantsulaia I, Trofimova S, Kobyliansky E, Livshits G. Relationship between obesity, adipocytokines, and blood pressure: possible common genetic and environmental factors. Am J Hum Biol 2009; 21: 84-90.
3. Korner A, Kiess W, Stumvoll M, Kovacs P. Polygenic contribution to obesity: genome-wide strategies reveal new targets. Front Horm Res 2008; 36: 12-36.
4. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
5. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Gen 2009; 10: 431-442.
6. Gonzalez-Sanchez JL, Zabena C, Martínez-Larrad MT, Martínez-Calatrava MJ, Pérez-Barba M, Serrano-Ríos M. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome. Clin Endocrinol (Oxford) 2008; 68: 724-729.
7. El Achhab Y, Meyre D, Bouatia-Naji N, Berraho M, Deweirder M, Vatin V et al. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes Metab 2009; 35: 37-42.
8. Peeters A, Beckers S, Verrijken A, Mertens I, Van Gaal L, Van Hul W. Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants. Endocrine 2009; 36: 103-109.
9. Santoro N, Cirillo G, Lepore MG, Palma A, Amato A, Savarese P et al. Effect of the rs997509 polymorphism on the association between ENPP1, metabolic syndrome, and impaired glucose tolerance in childhood obesity. J Clin Endocrinol Metab 2009; 94: 300-305.
10. Jenkinson CP, Coletta DK, Flechtner-Mors M, Hu SL, Fourcaudot MJ, Rodriguez LM et al. Association of genetic variation in ENPP1 with obesity-related phenotypes. Obesity (Silver Spring) 2008; 16: 1708-1713.
11. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin Vet al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 2005; 37: 863-867.
12. Meyre D, Bouatia-Naji N, Vatin V, Veslot J, Samson C, Tichet J et al. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia 2007; 50: 2090-2096.
13. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, Nigro A et al. Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 2008; 57: 3360-3364.
14. Bacci S, De Cosmo S, Prudente S, Trischitta V. ENPP1 gene, insulin resistance and related clinical outcomes. Curr Opin Clin Nutr Metab Care 2007; 10: 403-409.
15. Tanyolac-S, Bremer AA, Hodoglugil U, Movsesyan I, Pullinger CR, Heiner SW et al. Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects. Metab Syndr Relat Disord 2009; 7: 543-548.
16. Liang J, Fu M, Ciociola E, Chandalia M, Abate N. Role of ENPP1 on adipocyte maturation. PLoS one 2007; 2: e882.
17. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004; 164: 1199-1209.
18. Mornet E. Hypophosphatasia. Orphanet J Rare Dis 2007; 2: 40.
19. Zhang Y, Brown MA, Peach C, Russell G, Wordsworth BP. Investigation of the role of ENPP1 and TNAP genes in chondro-calcinosis. Rheumatology (Oxford) 2007; 46: 586-589.
20. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 2008; 29: 62-75.
21. Malkin I, Ermakov S, Kobyliansky E, Livshits G. Strong association between polymorphisms in ANKH locus and skeletal size traits. Hum Genet 2006; 120: 42-51.
22. Korostishevsky M, Vistoropsky Y, Malkin I, Kobyliansky E, Livshits G. Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus. Ann Hum Biol 2008; 35: 535-546.
23. Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity. J Clin Epidemiol 1991; 44: 545-550.
24. Piers LS, Rowley KG, Soares MJ, O'Dea K. Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry. Eur J Clin Nutr 2003; 57: 956-963.
25. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
26. Ostlund Jr RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Meta 1996; 81: 3909-3913.
27. Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome. Fertil Steril 2004; 82: 1364-1368.
28. Friedlander Y, Meiner V, Sharon N, Siscovick DS, Miserez AR. Leptin, insulin, and obesity-related phenotypes: genetic influences on levels and longitudinal changes. Obesity (Silver Spring) 2009; 17: 1458-1460.
29. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004; 59: 21-26.
30. Serrero G, Lepak NM, Hayashi J, Goodrich SP. Impaired epidermal growth factor production in genetically obese ob/ob mice. Am J Physiol 1993; 264: E800-E803.
31. Harrington M, Pond-Tor S, Boney CM. Role of Epidermal Growth Factor and ErbB2 receptors in 3T3-L1 adipogenesis. Obesity 2007; 15: 563-571.
32. Adachi H, Kurachi H, Homma H, Adachi K, Imai T, Morishige KI et al. Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro. Endocrinology 1994; 135: 1824-1830.
33. Threadgill D, Barrick CJ. Use of EGFR inhibitors to prevent or treat obesity. World Intellectual Property Organization, Patent Pub. No.: WO/2007/011702.
34. Livshits G, Karasik D, Kobyliansky E. Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes. J Bone Miner Res 2002; 17: 152-161.
35. Ermakov S, Malkin I, Keter M, Kobyliansky E, Livshits G. Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD. Ann Hum Genet 2008; 72: 510-518.
36. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics Books: Champaign, IL, 1988.
37. Trofimov S, Pantsulaia I, Kobyliansky E, Livshits G. Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/ macrophage-colony stimulating factor in a presumably healthy human population. Eur J Endocrinol 2004; 150: 305-311.
38. Lewontin R. The Genetic Basis of Evolutionary Change. Columbia University Press: Columbia, NY, 1974.
39. Malkin I, Dahm S, Suk A, Kobyliansky E, Toliat M, Ruf N et al. Association of ANKH gene polymorphisms with radiographic hand bone size and geometry in a Chuvasha population. Bone 2005; 36: 365-373.
40. StatSoft, Inc. STATISTICA (data analysis software system), 2005, version 7.1: http://www.statsoft.com.
41. Malkin I, Ginsburg E. Program package for pedigree analysis (version MAN-2009). Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 2009.
42. Malkin I, Bigman G, Matias R, Kalichman L, Seibel MJ, Kobyliansky E et al. Age-related changes of bone strength phenotypes: observational follow-up study of hand bone mineral density. Osteoporos Int 2006; 1: 59-68.
43. Rice T, Despre's JP, Daw EW, Gagnon J, Borecki IB, Pe'russae L et al. Familial resemblance for abdominal visceral fat: the HERITAGE family study. Int J Obes Relat Metab Disord 1997; 21: 1024-1031.
44. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotypeFphenotype associations. Eur J Hum Genet 2001; 9: 301-306.
45. Suk EK, Malkin I, Dahm S, Kalichman L, Ruf N, Kobyliansky E et al. Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Arthritis Res Ther 2005; 7: R1082-R1090.
46. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001; 29: 1165-1188.
47. Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, Aerts S et al. OregAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res 2008; 36: D107-D113.
48. Livshits G, Pantsulaia I, Trofimov S, Kobyliansky E. Genetic variation of circulating leptin is involved in genetic variation of hand bone size and geometry. Osteoporos Int 2003; 14: 476-483.
49. Böttcher Y, Körner A, Reinehr T, Enigk B, Kiess W, Stumvoll M et al. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. J Clin Endocrinol Metab 2006; 91: 4948-4952.
50. Frittitta L, Ercolino T, Bozzali M, Argiolas A, Graci S, Santagati MG et al. A cluster of three single nucleotide polymorphisms in the 3-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities. Diabetes 2001; 50: 1952-1955.
51. Stolerman ES, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA et al. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 2008; 57: 1971-1977.
52. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452.
53. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab 2009; 20: 230-236.
54. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469.
55. Auwerx J, Staels B. Leptin. Lancet 1998; 351: 737-742.
56. Shi Y, Yadav VK, Suda N, Liu XS, Guo XE, Myers Jr MG et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci USA 2008; 105: 20529-20533.
57. Beck Jr GR, Moran E, Knecht N. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 2003; 288: 288-300.
58. Kikkawa N, Ohno T, Nagata Y, Shiozuka M, Kogure T, Matsuda R. Ectopic calcification is caused by elevated levels of serum inorganic phosphate in mdx mice. Cell Struct Funct 2009; 34: 77-88.
59. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007; 3: e115.
60. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.